Financial Ratios

GLOBAL LONGLIFE HOSPITAL AND RESEARCH LTD.

NSE : NABSE : 543520ISIN CODE : INE0J2K01014Industry : Hospital & Healthcare ServicesHouse : Private
BSE41.38-0.67 (-1.59 %)
PREV CLOSE ( ) 42.05
OPEN PRICE ( ) 41.37
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2000
TODAY'S LOW / HIGH ( )41.37 41.38
52 WK LOW / HIGH ( ) 36.2561.7
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.745.112.92-1.231.95
   CEPS(Rs)2.856.744.791.805.03
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)58.9419.9814.4616.4117.65
   Tax Rate(%)32.5137.41-16.4718.9849.22
Margin Ratios
   Core EBITDA Margin(%)17.3125.0916.6210.1019.53
   EBIT Margin(%)13.3622.3012.824.1013.84
   Pre Tax Margin(%)11.5217.405.37-3.177.78
   PAT Margin (%)7.7810.896.26-2.573.95
   Cash Profit Margin (%)12.7414.3810.253.7710.18
Performance Ratios
   ROA(%)3.4711.105.72-2.193.40
   ROE(%)4.8229.6518.94-7.2311.05
   ROCE(%)6.6929.3613.493.6912.09
   Asset Turnover(x)0.451.020.910.850.86
   Sales/Fixed Asset(x)0.881.271.421.601.59
   Working Capital/Sales(x)0.91-13.5322.3614.0115.37
Efficiency Ratios
   Fixed Capital/Sales(x)1.130.790.700.630.63
   Receivable days144.4793.1478.7481.4091.86
   Inventory Days13.199.4316.7822.9221.33
   Payable days235.49381.81184.77294.78230.64
Valuation Parameters
   PER(x)25.730.000.000.000.00
   PCE(x)15.700.000.000.000.00
   Price/Book(x)0.760.000.000.000.00
   Yield(%)0.00
   EV/Net Sales(x)2.240.470.720.870.98
   EV/Core EBITDA(x)12.241.834.298.354.86
   EV/EBIT(x)16.792.115.6321.277.05
   EV/CE(x)0.710.490.710.760.84
   M Cap / Sales2.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)-28.380.34-2.51-2.880.00
   Core EBITDA Growth(%)-49.1153.8957.10-49.520.00
   EBIT Growth(%)-57.1074.56205.02-71.250.00
   PAT Growth(%)-48.8774.59337.36-163.190.00
   EPS Growth(%)-65.9174.59337.36-163.190.00
Financial Stability Ratios
   Total Debt/Equity(x)0.150.621.682.052.20
   Current Ratio(x)4.280.821.141.181.17
   Quick Ratio(x)4.170.761.061.021.02
   Interest Cover(x)7.274.551.720.562.28
   Total Debt/Mcap(x)0.20

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.